The Memorial Sloan Kettering Cancer Center (MSK) community extends our congratulations to Board of Trustees member David M. Rubenstein, who received the Presidential Medal of Freedom — the nation’s ...

MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of ...

A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell ...

Our laboratory uses a combination of structural biology and biophysical techniques to discover how ion channels and membrane-embedded enzymes function at the atomic level. The proteins we study are ...

Kimberly Feigin, MD, has been named Chief of the Breast Imaging Service within the Department of Radiology. Dr. Feigin has been a member of the service for 22 years and most recently served as Interim ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

The goal of our laboratory is to understand when, why, and how immune cells become unresponsive to tumors or self-destructive in autoimmune diseases. We develop genetic cancer mouse models that mimic ...

The immune system responds to viral infections by introducing a complex interplay of immune cells and factors, whose goal is to eliminate the intruding pathogen. One such effector cell in the ...

According to the latest statistics from the American Cancer Society, incidence rates of lung cancer are now higher in women than in men among people younger than 65 years. Overall, though, the news ...